Research Topics
Genomes and GenesSpecies | Nobuyuki KatoSummaryAffiliation: Okayama University Country: Japan Publications
| Collaborators
|
Detail Information
Publications
[Replication of hepatitis C virus genome]Nobuyuki Kato
Department of Tumor Virology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
Uirusu 58:191-8. 2008....
Genetic variation and dynamics of hepatitis C virus replicons in long-term cell cultureNobuyuki Kato
Department of Molecular Biology, Okayama University Graduate School of Medicine and Dentistry, 2 5 1 Shikata cho, Okayama 700 8558, Japan
J Gen Virol 86:645-56. 2005..Using this replicon cell culture system, it was demonstrated further that neither ribavirin nor its derivative mizoribine accelerated the mutation rate or the increase in the genetic diversity of HCV replicon...
Genetic variability and diversity of intracellular genome-length hepatitis C virus RNA in long-term cell cultureNobuyuki Kato
Department of Tumor Virology, Okayama University of Graduate School of Medicine, Okayama, Japan
Arch Virol 154:77-85. 2009..These results suggest that an HCV-RNA-replicating cell culture system would be useful for analysis of the evolutionary dynamics and variations of HCV...
Establishment of a hepatitis C virus subgenomic replicon derived from human hepatocytes infected in vitroNobuyuki Kato
Department of Molecular Biology, Okayama University Graduate School of Medicine and Dentistry, 2 5 1 Shikata cho, 700 8558, Okayama, Japan
Biochem Biophys Res Commun 306:756-66. 2003..Taken together, present results indicate that the replicon RNA library generated using an in vitro HCV infection system is useful for the establishment of an HCV subgenomic replicon...
[Hepatitis virus--the approach to clarification of the mechanisms of virus proliferation and the development of its control means]Nobuyuki Kato
Okayama University Graduate School of Medicine and Dentistry, Department of Molecular Biology, Shikata-cho, 2-5-1, Okayama 700-8558
Uirusu 52:157-62. 2002
Molecular virology of hepatitis C virusN Kato
Department of Molecular Biology, Okayama University Graduate School of Medicine and Dentistry, Japan
Acta Med Okayama 55:133-59. 2001..The enormous body of information collected thus far in the field of HCV research is summarized below, and an overview of the current status of HCV molecular virology of HCV is provided...
A new living cell-based assay system for monitoring genome-length hepatitis C virus RNA replicationHiromichi Dansako
Department of Molecular Biology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
Virus Res 137:72-9. 2008..The OGF7 assay system is expected to be the most time-saving and inexpensive assay system for high-throughput screening of anti-HCV reagents...
Anti-ulcer agent teprenone inhibits hepatitis C virus replication: potential treatment for hepatitis CMasanori Ikeda
Department of Tumor Virology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
Liver Int 31:871-80. 2011..Geranylgeranyl pyrophosphate (GGPP) is a substrate for geranylgeranyltransferase. Therefore, we examined the potential of geranyl compounds with chemical structures similar to those of GGPP to inhibit HCV RNA replication...
Establishment of hepatitis C virus replicon cell lines possessing interferon-resistant phenotypeKatsuyuki Namba
Department of Molecular Biology, Okayama University Graduate School of Medicine and Dentistry, 2-5-1 Shikata-cho, Okayama 700-8558, Japan
Biochem Biophys Res Commun 323:299-309. 2004..These newly established HCV replicon cell lines possessing IFN-resistant phenotypes are the first useful tools for understanding the mechanisms by which HCV acquires IFN resistance in vivo...
Epigenetic silencing of interferon-inducible genes is implicated in interferon resistance of hepatitis C virus replicon-harboring cellsKazuhito Naka
Department of Molecular Biology, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Okayama 700-8558, Japan
J Hepatol 44:869-78. 2006..CONCLUSIONS: The present results suggest that the epigenetic silencing of IFN-stimulated genes is implicated in the acquisition of a partially IFN-resistant phenotype of HCV replicon-harboring cells...
HCV genotype 1b chimeric replicon with NS5B of JFH-1 exhibited resistance to cyclosporine AKen ichi Abe
Department of Tumor Virology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Shikata cho, Okayama, Japan
Arch Virol 154:1671-7. 2009..Here, we demonstrated that NS5B of JFH-1 contributed to this strain's CsA-resistant phenotype. NS5B and CyPA are significant for determining HCV's sensitivity to CsA...
Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter systemMasanori Ikeda
Department of Molecular Biology, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan
Biochem Biophys Res Commun 329:1350-9. 2005..This culture system is useful tool for the study of HCV replication and mass screening for anti-HCV reagents...
The DNA damage sensors ataxia-telangiectasia mutated kinase and checkpoint kinase 2 are required for hepatitis C virus RNA replicationYasuo Ariumi
Department of Molecular Biology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2 5 1, Shikata cho, Okayama 700 8558, Japan
J Virol 82:9639-46. 2008..Taken together, these results suggest that the ATM signaling pathway is critical for HCV RNA replication and may represent a novel target for the clinical treatment of patients with chronic hepatitis C...
Tandem repeats of lactoferrin-derived anti-hepatitis C virus peptide enhance antiviral activity in cultured human hepatocytesKen ichi Abe
Department of Molecular Biology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Japan
Microbiol Immunol 51:117-25. 2007..These results suggest that tandem repeats of LF-derived anti-HCV peptide are useful as anti-HCV reagents...
Amino acid substitutions of hepatitis C virus core protein are not associated with intracellular antiviral response to interferon-α in vitroFusao Ikeda
Department of Tumor Virology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
Liver Int 30:1324-31. 2010....
Different anti-HCV profiles of statins and their potential for combination therapy with interferonMasanori Ikeda
Department of Molecular Biology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
Hepatology 44:117-25. 2006..In combination with IFN, fluvastatin also exhibited a synergistic inhibitory effect. In conclusion, statins, especially fluvastatin, could be potentially useful as new anti-HCV reagents in combination with IFN...
New efficient replication system with hepatitis C virus genome derived from a patient with acute hepatitis CKyoko Mori
Department of Molecular Biology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2 5 1 Shikata cho, Okayama 700 8558, Japan
Biochem Biophys Res Commun 371:104-9. 2008..Reporter assay analysis suggests that the diverse effects of interferon-gamma are due to the difference in HCV strains, but not the cellular environment...
Limited suppression of the interferon-beta production by hepatitis C virus serine protease in cultured human hepatocytesHiromichi Dansako
Department of Molecular Biology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Japan
FEBS J 274:4161-76. 2007..Taken together, our findings suggest that the blocking of the interferon production by NS3-4A is not sufficient in HCV-infected hepatocyte cells...
cDNA microarray analysis of lactoferrin expression in non-neoplastic human hepatocyte PH5CH8 cellsTakahiko Tamura
Department of Molecular Biology, Okayama University Graduate School of Medicine and Dentistry, 2-5-1 Shikata-cho, Okayama 700-8558, Japan
Biochim Biophys Acta 1721:73-80. 2005..This modulation is one of the cellular responses that the GABA-B receptor modifies. This is the first report of microarray analysis applied to search inclusively for the target genes of LF...
Replicons from genotype 1b HCV-positive sera exhibit diverse sensitivities to anti-HCV reagentsGo Nishimura
Department of Tumor Virology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2 5 1 Shikata cho, Okayama 700 8558, Japan
Antiviral Res 82:42-50. 2009..44 IU/ml vs. 1.37 IU/ml) and cyclosporine A (EC(50): 0.71 microg/ml vs. 0.96 microg/ml). These replicons are thus useful tools for examining the mechanism of anti-HCV activity, especially in IFN-lambda and statins...
Mechanism of action of ribavirin in a novel hepatitis C virus replication cell systemKyoko Mori
Department of Tumor Virology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2 5 1 Shikata cho, Okayama 700 8558, Japan
Virus Res 157:61-70. 2011..In conclusion, we demonstrated for the first time that inhibition of IMPDH is a major antiviral target by which RBV at clinically achievable concentrations inhibits HCV RNA replication...
Promotion of microsatellite instability by hepatitis C virus core protein in human non-neoplastic hepatocyte cellsAtsushi Naganuma
Department of Molecular Biology, Okayama University Graduate School of Medicine and Dentistry, 2-5-1 Shikata-cho, Okayama 700-8558, Japan
Cancer Res 64:1307-14. 2004..This is the first report to demonstrate that the core protein may disturb the DNA repair system...
cDNA microarray analysis to compare HCV subgenomic replicon cells with their cured cellsKen-ichi Abe
Department of Molecular Biology, Okayama University Graduate School of Medicine and Dentistry, 2-5-1 Shikata-cho, Okayama 700-8558, Japan
Virus Res 107:73-81. 2005..Our microarray analysis demonstrated that HCV subgenomic replicons can change the gene expression profiles of host cells, and it allowed us to compile the first list of genes that the replicons transcriptionally regulate...
DDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replicationYasuo Ariumi
Department of Molecular Biology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2 5 1, Shikata cho, Okayama 700 8558, Japan
J Virol 81:13922-6. 2007..Thus, DDX3 is required for HCV RNA replication...
Efficient replication systems for hepatitis C virus using a new human hepatoma cell lineNobuyuki Kato
Department of Tumor Virology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2 5 1 Shikata cho, Okayama 700 8558, Japan
Virus Res 146:41-50. 2009..Finally, Li23-derived cells persistently produced infectious virus of an HCV strain. Li23-derived cells are potentially useful for understanding the HCV life cycle and for finding antiviral targets...
Cell culture-adaptive NS3 mutations required for the robust replication of genome-length hepatitis C virus RNAKen ichi Abe
Department of Molecular Biology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
Virus Res 125:88-97. 2007..These findings suggest that specific viral factors may affect the replication level of genome-length HCV RNA...
Oncostatin M synergistically inhibits HCV RNA replication in combination with interferon-alphaMasanori Ikeda
Department of Tumor Virology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2 5 1 Shikata cho, Okayama 700 8558, Japan
FEBS Lett 583:1434-8. 2009..OSM is a candidate anti-HCV reagent and may improve the current IFN therapy for patients with chronic hepatitis C...
Mizoribine inhibits hepatitis C virus RNA replication: effect of combination with interferon-alphaKazuhito Naka
Department of Molecular Biology, Okayama University Graduate School of Medicine and Dentistry, 2-5-1 Shikata-cho, Okayama 700-8558, Japan
Biochem Biophys Res Commun 330:871-9. 2005..Since mizoribine is currently used in several clinical applications and has not been associated with severe side effects, mizoribine is considered to be of potential use as a new anti-HCV reagent in combination with IFN-alpha...
Oxidative stress induces anti-hepatitis C virus status via the activation of extracellular signal-regulated kinaseMasahiko Yano
Department of Tumor Virology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
Hepatology 50:678-88. 2009..This intracellular modulation is expected to be a therapeutic target for the suppression of HCV RNA replication...
Identification of host genes showing differential expression profiles with cell-based long-term replication of hepatitis C virus RNAHiroe Sejima
Department of Tumor Virology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2 5 1, Shikata cho, Okayama 700 8558, Japan
Virus Res 167:74-85. 2012..5-year replication of HCV RNA. These genes may play roles in the optimization of the environment in HCV RNA replication, or may play key roles in the progression of HCV-associated hepatic diseases...
Double-stranded RNA-induced interferon-beta and inflammatory cytokine production modulated by hepatitis C virus serine proteases derived from patients with hepatic diseasesHiromichi Dansako
Department of Tumor Virology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2 5 1 Shikata cho, Okayama 700 8558, Japan
Arch Virol 154:801-10. 2009..These results suggest that the inhibitory effects of NS3-4A on antiviral signaling pathways are limited to the Cardif-mediated pathway in human hepatocytes...
Interferon resistance of hepatitis C virus replicon-harbouring cells is caused by functional disruption of type I interferon receptorsKazuhito Naka
Department of Molecular Biology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama 700-8558, Japan
J Gen Virol 86:2787-92. 2005..Moreover, it was shown that ectopic expression of wild-type IFNAR1 in IFN-resistant phenotype, replicon-harbouring cells possessing the IFNAR1 mutant restored type I IFN signalling...
The ESCRT system is required for hepatitis C virus productionYasuo Ariumi
Department of Tumor Virology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
PLoS ONE 6:e14517. 2011..Retroviruses and some other enveloped viruses require an endosomal sorting complex required for transport (ESCRT) components and their associated proteins for their budding process...
Development of a drug assay system with hepatitis C virus genome derived from a patient with acute hepatitis CKyoko Mori
Department of Tumor Virology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2 5 1 Shikata cho, Okayama, 700 8558, Japan
Virus Genes 44:374-81. 2012..Taken together, these results suggest that the AH1R assay system is useful for the objective evaluation of anti-HCV reagents and for the discovery of different classes of anti-HCV reagents...
Differential activation of interferon-inducible genes by hepatitis C virus core protein mediated by the interferon stimulated response elementHiromichi Dansako
Department of Molecular Biology, Okayama University Graduate School of Medicine and Dentistry, 2-5-1 Shikata-cho, Okayama 700-8558, Japan
Virus Res 97:17-30. 2003....
Development of hepatitis C virus production reporter-assay systems using two different hepatoma cell linesMidori Takeda
Department of Tumor Virology, Okayama University, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700 8544, Japan
J Gen Virol 93:1422-31. 2012..In this study, we developed HCV JFH-1 reporter-assay systems using two distinct hepatoma cell lines, HuH-7 and Li23. The mutations in NS5B resulted in different effects on strains O and JFH-1 HCV RNA replication...
Arsenic trioxide inhibits hepatitis C virus RNA replication through modulation of the glutathione redox system and oxidative stressMisao Kuroki
Department of Tumor Virology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2 5 1, Shikata cho, Okayama 700 8558, Japan
J Virol 83:2338-48. 2009..Taken together, these findings suggest that ATO inhibits the HCV RNA replication through modulation of the glutathione redox system and oxidative stress...
Comprehensive analysis of the effects of ordinary nutrients on hepatitis C virus RNA replication in cell cultureMasahiko Yano
Department of Molecular Biology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2 5 1 Shikata cho, Okayama 700 8558, Japan
Antimicrob Agents Chemother 51:2016-27. 2007....
Serum-free cell culture system supplemented with lipid-rich albumin for hepatitis C virus (strain O of genotype 1b) replicationKen ichi Abe
Department of Molecular Biology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2 5 1, Shikata cho, Okayama 700 8558, Japan
Virus Res 125:162-8. 2007..This cell culture system is expected to be a useful tool for vaccine development, as well as for further investigation of cellular factors that are essential for HCV RNA replication...
Hepatitis C virus proteins exhibit conflicting effects on the interferon system in human hepatocyte cellsHiromichi Dansako
Department of Molecular Biology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama 700-8558, Japan
Biochem Biophys Res Commun 336:458-68. 2005....
Hepatitis C virus NS5B delays cell cycle progression by inducing interferon-beta via Toll-like receptor 3 signaling pathway without replicating viral genomesKazuhito Naka
Department of Molecular Biology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama 700 8558, Japan
Virology 346:348-62. 2006..Our findings revealed that NS5B induced IFN-beta through the TLR3 signaling pathway in immortalized human hepatocytes even without replicating viral genomes...
Life style-related diseases of the digestive system: cell culture system for the screening of anti-hepatitis C virus (HCV) reagents: suppression of HCV replication by statins and synergistic action with interferonMasanori Ikeda
Department of Molecular Biology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
J Pharmacol Sci 105:145-50. 2007..Furthermore, statins enhanced the anti-HCV effect of interferon in combination. Statins may be a promising candidate for the adjuvant in interferon therapy and may improve the efficiency of the current interferon and ribavirin therapy...
Hepatitis C virus quasispecies in cancerous and noncancerous hepatic lesions: the core protein-encoding regionShahjalal S Alam
Department of Molecular Biology, Okayama University Graduate School of Medicine and Dentistry, Japan
Acta Med Okayama 56:141-7. 2002....
PML tumor suppressor protein is required for HCV productionMisao Kuroki
Department of Tumor Virology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2 5 1, Shikata cho, Okayama 700 8558, Japan
Biochem Biophys Res Commun 430:592-7. 2013..Finally, we also demonstrated that INI1 and DDX5, the PML-related proteins, are involved in HCV production. Taken together, these findings suggest that PML is required for HCV production...
Modulation of host metabolism as a target of new antiviralsMasanori Ikeda
Department of Molecular Biology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2 5 1, Shikata cho, Okayama 700 8558, Japan
Adv Drug Deliv Rev 59:1277-89. 2007..These host molecules are also candidate targets for antivirals. Here, we describe the recent progress regarding the anti-HCV reagents targeting host metabolism...
Development of a hepatitis C virus relapse model using genome-length hepatitis C virus ribonucleic acid-harboring cells possessing the interferon-alpha-resistance phenotypeYoshinari Kawai
Department of Tumor Virology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
Hepatol Res 39:898-909. 2009..Thus anti-HCV reagents, which have a mechanism different from IFN-alpha, were shown to be useful for preventing a relapse of IFN-alpha-resistant HCV...
Identification of a lactoferrin-derived peptide possessing binding activity to hepatitis C virus E2 envelope proteinAkito Nozaki
Department of Molecular Biology, Okayama University Graduate School of Medicine and Dentistry, Japan
J Biol Chem 278:10162-73. 2003..These results led us to consider the development of an effective anti-HCV peptide. This is the first identification of a natural protein-derived peptide that specifically binds to HCV E2 protein and prevents HCV infection...
Plural assay systems derived from different cell lines and hepatitis C virus strains are required for the objective evaluation of anti-hepatitis C virus reagentsYouki Ueda
Department of Tumor Virology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2 5 1 Shikata cho, Okayama 700 8558, Japan
Biochem Biophys Res Commun 409:663-8. 2011..Therefore, we conclude that plural HCV assay systems developed using different cell lines or HCV strains are required for the objective evaluation of anti-HCV reagents...
[Mode of proliferation of HCV in human lymphocytes]Nobuyuki Kato
Department of Molecular Biology, Okayama University Graduate School of Medicine and Dentistry
Nippon Rinsho 62:101-6. 2004
[Gene organization of hepatitis C virus and its sequence diversity]Nobuyuki Kato
Department of Molecular Biology, Okayama University Graduate School of Medicine and Dentistry
Nippon Rinsho 62:26-31. 2004
Genome of human hepatitis C virus (HCV): gene organization, sequence diversity, and variationN Kato
Department of Molecular Biology, Institute of Cellular and Molecular Biology, Okayama University Medical School, Japan
Microb Comp Genomics 5:129-51. 2000..The hypervariable region 1 found within the envelope E2 protein was shown to be a major site for the genetic evolution of HCV after the onset of hepatitis, and might be involved in escape from the host immunesurveillance system...
Eradication of hepatitis C virus subgenomic replicon by interferon results in aberrant retinol-related protein expressionKazuko Koike
Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700 8558, Japan
Acta Med Okayama 66:461-8. 2012..The alteration in RBP expression was also confirmed by ELISA and Western blot analysis. We conclude that protein expression profiling demonstrated that HCV replicon eradication affected retinol-related protein expression...
Quantitative method of intracellular hepatitis C virus RNA using LightCycler PCRAkito Nozaki
Department of Molecular Biology, Okayama University Graduate School of Medicine and Dentistry, Japan
Acta Med Okayama 56:107-10. 2002..We demonstrated that this method was useful for the evaluation of antiviral reagents using HCV-infected human cultured cells...
[Recent advances of basic research and clinical application of lactoferrin as an antiviral reagent against chronic hepatitis C]Akito Nozaki
Department of Molecular Biology, Okayama University Graduate School of Medicine and Dentistry
Nippon Rinsho 60:819-29. 2002..Further clinical trials showed that lactoferrin is a promising candidate for adjuvant therapy with interferon in patients with chronic hepatitis C...
Primary structure and expression of peroxisomal acetylspermidine oxidase in the methylotrophic yeast Candida boidiniiM Nishikawa
Research Institute for Biological Sciences Okayama, Okayama, Japan
FEBS Lett 476:150-4. 2000..boidinii. To our knowledge, this is the first report on the gene coding for ASOD that can catalyze the oxidation of N-acetylated polyamine as a substrate, from any type of organism...
Identification of novel epoxide inhibitors of hepatitis C virus replication using a high-throughput screenLee F Peng
GI Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA
Antimicrob Agents Chemother 51:3756-9. 2007..5 microM). We then synthesized an analog of these compounds with optimized activity...
A cell-based, high-throughput screen for small molecule regulators of hepatitis C virus replicationSun Suk Kim
Gastrointestinal Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA
Gastroenterology 132:311-20. 2007..Thus, the identification of more effective and better tolerated agents is a high priority. We applied chemical biology to screen small molecules that regulate HCV...
Possible molecular mechanism of the relationship between NS5B polymorphisms and early clearance of hepatitis C virus during interferon plus ribavirin treatmentMitsuyasu Nakamura
Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Keio University, Shinanomachi, Shinjuku ku, Tokyo, Japan
J Med Virol 80:632-9. 2008..Our results suggested that this mutation at least partly contributes to resistance to early viral clearance during interferon and ribavirin combination therapy...
Subgenomic replicon derived from a cell line infected with the hepatitis C virusHiroe Kishine
Department of Viral Oncology, Institute for Virus Research, Kyoto University, 53 Kawara-cho Shogo-in, Sakyo-ku, Kyoto 606-8507, Japan
Biochem Biophys Res Commun 293:993-9. 2002..These results suggest that the HCV genome obtained from an in vitro HCV infection system with cultured cells can be used to develop a subgenomic replicon system with diverse HCV sequences...
Differential effects of calcineurin inhibitors, tacrolimus and cyclosporin a, on interferon-induced antiviral protein in human hepatocyte cellsKumi Hirano
Department of Clinical Pharmaceutics, Nagasaki University, Nagasaki, Japan
Liver Transpl 14:292-8. 2008..Moreover, the replication of HCV was activated. This phenomenon is detrimental to IFN therapy after liver transplantation, and the selection of calcineurin inhibitors may warrant further discussion depending on the transplant situation...
Zinc is a negative regulator of hepatitis C virus RNA replicationKazuhisa Yuasa
Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan
Liver Int 26:1111-8. 2006..Zinc supplementation thus appears to offer a novel approach to the development of future strategies for the treatment of intractable chronic hepatitis C...
Adenovirus-mediated gene transfer of interferon alpha inhibits hepatitis C virus replication in hepatocytesKoichi Suzuki
Genetics Division, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan
Biochem Biophys Res Commun 307:814-9. 2003..This study supports the development of IFN-alpha gene therapy for HCV-associated liver diseases...
[Molecular mechanisms on interferon resistance of hepatitis C virus]Kazuhito Naka
Tanpakushitsu Kakusan Koso 49:526-33. 2004
Diverse effects of cyclosporine on hepatitis C virus strain replicationNaoto Ishii
Laboratory of Human Tumor Viruses, Department of Viral Oncology, Institute for Virus Research, Kyoto University, 53 Kawaharacho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan
J Virol 80:4510-20. 2006..These findings provide an insight into the mechanisms of diversity governing virus-cell interactions and in the sensitivity of these strains to antiviral agents...
Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytesKui Li
Department of Microbiology and Immunology, Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas 77555 1019, USA
J Biol Chem 280:16739-47. 2005..We conclude that hepatocytes contain two distinct antiviral signaling pathways leading to expression of type I IFNs, one dependent upon TLR3 and the other dependent on RIG-I, with little cross-talk between these pathways...
NS3 protein of Hepatitis C virus associates with the tumour suppressor p53 and inhibits its function in an NS3 sequence-dependent mannerLin Deng
Division of Microbiology, Kobe University Graduate School of Medicine, Kobe 650 0017, Japan
J Gen Virol 87:1703-13. 2006..Our results collectively suggest the possibility that NS3 plays an important role in the hepatocarcinogenesis of HCV by interacting differentially with p53 in an NS3 sequence-dependent manner...
Complications of percutaneous radiofrequency ablation for hepato-cellular carcinoma: imaging spectrum and managementMasaaki Akahane
Departments of Radiology, Graduate School of Medicine, University of Tokyo, 7 3 1 Hongo, Bunkyo ku, Tokyo 113 8655, Japan
Radiographics 25:S57-68. 2005..Because an early and accurate diagnosis is necessary for proper management, radiologists should be familiar with the imaging features of each type of complication...
Efficient formation of vesicular stomatitis virus pseudotypes bearing the native forms of hepatitis C virus envelope proteins detected after sonicationKazushi Tamura
Department of Virology and Preventive Medicine, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan
Microbes Infect 7:29-40. 2005..The VSV pseudotypes developed here would be useful for analyzing the early stages of HCV infection...
